Jane C. Davies

Medicine · Health Sciences

68h-index23.1kcitations760works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(425), Neonatal Respiratory Health Research(180), Tracheal and airway disorders(116), Pediatric health and respiratory diseases(56), Respiratory viral infections research(52)

Publications752 total

Current Epidemiology and Infection Characteristics of Non- <i>Aspergillus</i> Mold Infections: A Multicenter Study in Australia and New Zealand
Clinical Infectious Diseases·2026
F/HN-pseudotyped lentiviral vector efficiently transduces non-human primate airways with no evidence of relevant toxicity
Molecular Therapy Advances·2025Open Access
What does transformation in Higher Education research culture look like? Evidence from action research within a diverse post-1992 department
Routledge Open Research·2025Open Access
Potential gene therapies for cystic fibrosis: a plain language summary for non-specialists and the lay community
Future Rare Diseases·2025
S69 Reduction in serum markers of inflammation in people with cystic fibrosis who are chronically infected with pseudomonas aeruginosa is seen after treatment with Elexacaftor/Tezacaftor/Ivacaftor
2025
P183 Enhancing antibiotic effectiveness using the repurposed multiple sclerosis drug, glatiramer acetate, to compromise membrane integrity of CF-relevant pathogenic bacteria
2025
S70 Oxygen enhanced (OE-)MRI and multiple breath washout with short extension (MBWShX) reveal lung disease progression in people with cystic fibrosis despite triple CFTR modulator therapy
2025
What does transformation in Higher Education research culture look like? Evidence from action research within a diverse post-1992 department
Routledge Open Research·2025Open Access
Changes in Airway Sampling and <i>Pseudomonas aeruginosa</i> Isolation after the Introduction of Elexacaftor/Tezacaftor/Ivacaftor
Annals of the American Thoracic Society·2025
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A 192-Week, Phase 3, Open-Label Extension Study.
PubMed·2025
594 How dietitians support diet quality in cystic fibrosis: insights into assessment, recommendations, and behaviour change
Journal of Cystic Fibrosis·2025
108 A phase II study (CLAIRAFLY) evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of the DPP1 (CatC) inhibitor BI 1291583 in cystic fibrosis: Effects of CFTR modulator therapy use
Journal of Cystic Fibrosis·2025
577 Impact of elexacaftor, tezacaftor and ivacaftor on hepatic status after 4- 5 years: results of the combined PROMISE and RECOVER studies
Journal of Cystic Fibrosis·2025
Biomarkers in primary ciliary dyskinesia (PCD): A systematic review
2025
The effect of Elexacaftor/Tezacaftor/Ivacaftor (ETI) on bronchial tapering as marker of bronchial dilatation in people with CF aged 12 above (RECOVER study)
2025
Assessing lung disease progression in people with cystic fibrosis (pwCF) on elexacaftor/tezacaftor/ivacaftor (ETI) with dynamic functional lung MRI
2025
Heart rate variability from pulse oximetry during cystic fibrosis exacerbations
2025
Choice of Segmentation Algorithm to Determine Ventilated Volume Fraction from Oxygen-Enhanced MRI in Cystic Fibrosis and Healthy Volunteers
Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition·2025
ENHANCE: A community partnership charting the evolution of early life CF disease manifestations in a new era of management
ERJ Open Research·2025Open Access
Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluation
Thorax·2025· 1 citedOpen Access
page 1 of 38Next →

Frequent Co-authors

Eric W.F.W. Alton(16), Andrew Bush(12), Claire Wainwright(10), Félix Ratjen(8), Steve Cunningham(8), Margaret Rosenfeld(8), Isabelle Sermet‐Gaudelus(7), Simon Tian(7), Steven M. Rowe(6), Susanna A. McColley(6), À. Munck(6), Deborah R. Gill(6), Uta Griesenbach(6), Stephen C. Hyde(6), J. Alastair Innes(6), David J. Porteous(6), Elizabeth Tullis(5), Kevin W Southern(5), Carlos Milla(5), Nicolas Regamey(5)